MPM BioImpact’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
4,411,821
-482,523
| -10% | -$116K | 0.18% | 43 |
|
|
2025
Q1 | $964K | Sell |
4,894,344
-201,568
| -4% | -$39.7K | 0.17% | 41 |
|
|
2024
Q4 | $2.75M | Hold |
5,095,912
| – | – | 0.39% | 45 |
|
|
2024
Q3 | $4.84M | Hold |
5,095,912
| – | – | 0.73% | 38 |
|
|
2024
Q2 | $4.97M | Hold |
5,095,912
| – | – | 0.77% | 40 |
|
|
2024
Q1 | $8.05M | Hold |
5,095,912
| – | – | 1.29% | 31 |
|
|
2023
Q4 | $4.04M | Hold |
5,095,912
| – | – | 0.95% | 27 |
|
|
2023
Q3 | $3.97M | Hold |
5,095,912
| – | – | 1.06% | 27 |
|
|
2023
Q2 | $4.71M | Buy |
+5,095,912
| New | +$4.71M | 0.95% | 28 |
|